Spero Therapeutics SPRO is set to give its latest quarterly earnings report on Monday, 2023-03-13. Here's what investors need to know before the announcement. Analysts estimate that Spero Therapeutics will report an earnings per share (EPS) of $0.04.  Spero Therapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter. New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast). Last quarter the company missed EPS by $0.03, which was followed by a 7.39% drop in the share price the next day. Here's a look at Spero Therapeutics's past performance and the resulting price change: 


Quarter
Q3 2022
Q2 2022
Q1 2022
Q4 2021




EPS Estimate
-0.30
-0.54
-0.87
-0.75


EPS Actual
-0.33
-0.51
-1.01
-0.90


Price Change %
-7.39%
-8.35%
-3.51%
-18.28%


  Shares of Spero Therapeutics were trading at $1.51 as of March 09. Over the last 52-week period, shares are down 81.7%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.  To track all earnings releases for Spero Therapeutics visit their earnings calendar on our site. This article was generated by Benzinga's automated content engine and reviewed by an editor. Â© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. Sort by estimates, projected upside, profit surprises, and more to easily find new stocks to invest in or check up on your portfolio. Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.